EFMS.A.
Other research and experimental development on natural sciences and engineering
Overview
Efm is a company that has developed the Cardiac Dynamic System (CDS), a telemedical device designed for the immediate diagnosis of critical heart conditions, particularly those related to dyspnea. This system aims to reduce the time required for diagnosing cardiac diseases, which typically involves multiple tests and can take several weeks. Efm focuses on improving patient outcomes through early and accurate diagnosis of cardiovascular disorders.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
News
Mudisocard Project within the PCI Deeptech Accelerator
MudisoCard - project within PCI Deeptech Accelerator
Asia: EFM Asia Limited Suite C, Level, World Trust Tower 50 Stanley Street, Central, Hong Kong. China
Grants for Eurogrants
Grants for Eurogrants
Two major milestones in March
Asia: EFM Asia Limited Suite C, Level, World Trust Tower 50 Stanley Street, Central, Hong Kong. China
EFM has received the Management System Certificate
Asia: EFM Asia Limited Suite C, Level, World Trust Tower 50 Stanley Street, Central, Hong Kong. China
Industry
Bank accounts
Registered as a VAT taxpayer on 2022-11-26. Active
25 1090 1056 0000 0001 5724 6392- 91 1090 1056 0000 0001 5724 6368
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
MSiG notices
| Publication date | Event | |
|---|---|---|
| Nov 23, 2023 | Transformation |
Public aid
4 public aid cases recorded, with a total value of $285,062.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Dec 31, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości | |
| Dec 1, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | Podkarpackie Centrum Innowacji sp. z o.o. | |
| Sep 9, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości |
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
The following person or persons are authorized to represent the company and to make declarations on its behalf with respect to the company's property and non-property rights and obligations: 1. in the case of a one-person management board – the President of the Management Board independently; 2. in the case of a multi-member management board – two members of the management board acting jointly or a member of the management board acting jointly with a commercial proxy.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Advanced Diagnostic Equipmentsp. z o.o. | $43,171.56 | adediabetics.pl | ||
| Edoktor24 Servicessp. z o.o. | $34,089.64 | edoktor24.pl | ||
| SimplicardiacS.A. | $28,951.71 | simplicardiac.com |
Change history
| Date | Event | |
|---|---|---|
| 2026-10-01 | Share capital change (106,880.90 PLN → 128,769.90 PLN) | |
| 2025-07-11 | Share capital change (100,000.00 PLN → 106,880.90 PLN) | |
| 2024-04-24 | Name change (Efm R&d → Efm) | |
| 2023-11-14 | Entered in the register |
FAQ
Last updated: 2026-10-03